US414891A
(en)
*
|
|
1889-11-12 |
|
Teen twenty-fourths to bernard j |
FR2331336A1
(fr)
|
1975-11-14 |
1977-06-10 |
Rolland Sa A |
Acides oxy-4,4' bis(phenoxy-2 alcanocarboxyliques), leurs derives et leur application comme medicament
|
US4920132A
(en)
|
1987-11-03 |
1990-04-24 |
Rorer Pharmaceutical Corp. |
Quinoline derivatives and use thereof as antagonists of leukotriene D4
|
US5324743A
(en)
|
1992-12-10 |
1994-06-28 |
Eli Lilly And Company |
Leukotriene B4 antagonists
|
IL109451A0
(en)
|
1993-04-29 |
1994-07-31 |
Zeneca Ltd |
Heterocyclic derivatives
|
AU1856997A
(en)
|
1996-02-02 |
1997-08-22 |
Merck & Co., Inc. |
Method for raising hdl cholesterol levels
|
ES2202582T3
(es)
|
1996-02-02 |
2004-04-01 |
MERCK & CO., INC. |
Agentes antidiabeticos.
|
DE69733154T2
(de)
|
1996-02-02 |
2006-03-09 |
Merck & Co., Inc. |
Verfahren zur behandlung von diabetes und verwandter krankheitszustände.
|
DE69728267T2
(de)
|
1996-02-02 |
2005-02-24 |
Merck & Co., Inc. |
Antidiabetisches mittel
|
WO1997028137A1
(en)
|
1996-02-02 |
1997-08-07 |
Merck & Co., Inc. |
Heterocyclic derivatives as antidiabetic and antiobesity agents
|
WO1997043241A1
(fr)
|
1996-05-13 |
1997-11-20 |
Nippon Shinyaku Co., Ltd. |
Composes d'ethylene substitue et medicaments
|
US5773469A
(en)
|
1996-06-18 |
1998-06-30 |
Ortho Pharmaceutical Corporation |
Diaryl antimicrobial agents
|
EP0948327B1
(de)
|
1996-12-23 |
2006-03-08 |
Merck & Co., Inc. |
Antidiabetische mittel
|
ES2320181T3
(es)
|
1997-07-24 |
2009-05-19 |
Astellas Pharma Inc. |
Composiciones farmaceuticas que tienen un efecto reductor del colesterol.
|
HUP0101022A1
(hu)
|
1997-10-17 |
2001-10-28 |
Aventis Pharmaceuticals Products Inc. |
Kinolinszármazékok gyógyászati alkalmazása
|
WO2000023416A1
(en)
*
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
WO2000023415A1
(en)
*
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
JP2002542218A
(ja)
*
|
1999-04-20 |
2002-12-10 |
ノボ ノルディスク アクティーゼルスカブ |
新規な化合物、それらの製造および使用
|
US6972294B1
(en)
|
1999-04-20 |
2005-12-06 |
Novo Nordisk, A/S |
Compounds, their preparation and use
|
JP2003500432A
(ja)
|
1999-06-01 |
2003-01-07 |
ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター |
ジフェニルエーテル誘導体を用いて脱毛症を処置する方法
|
GB9914977D0
(en)
|
1999-06-25 |
1999-08-25 |
Glaxo Group Ltd |
Chemical compounds
|
TWI262185B
(en)
|
1999-10-01 |
2006-09-21 |
Eisai Co Ltd |
Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
|
US6369098B1
(en)
|
1999-10-05 |
2002-04-09 |
Bethesda Pharmaceuticals, Inc. |
Dithiolane derivatives
|
PL356745A1
(en)
|
1999-11-10 |
2004-06-28 |
Takeda Chemical Industries, Ltd |
Body weight gain inhibitors
|
CN1390139A
(zh)
|
1999-11-11 |
2003-01-08 |
伊莱利利公司 |
用于治疗癌症的肿瘤细胞溶解组合物
|
US6569901B2
(en)
|
2000-01-28 |
2003-05-27 |
Novo Nordisk A/S |
Alkynyl-substituted propionic acid derivatives, their preparation and use
|
WO2001055086A1
(en)
|
2000-01-28 |
2001-08-02 |
Novo Nordisk A/S |
Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity
|
US6555577B1
(en)
|
2000-01-28 |
2003-04-29 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
JP2003520838A
(ja)
|
2000-01-28 |
2003-07-08 |
ノボ ノルディスク アクティーゼルスカブ |
新規化合物、それらの製造および使用。
|
CA2400021A1
(en)
|
2000-02-18 |
2001-08-23 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
KR20020081424A
(ko)
|
2000-03-09 |
2002-10-26 |
아벤티스 파마 도이칠란트 게엠베하 |
Ppar 매개인자의 치료학적 용도
|
US6448293B1
(en)
|
2000-03-31 |
2002-09-10 |
Pfizer Inc. |
Diphenyl ether compounds useful in therapy
|
JP2001354671A
(ja)
|
2000-04-14 |
2001-12-25 |
Nippon Chemiphar Co Ltd |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
AU2001277723A1
(en)
|
2000-08-11 |
2002-02-25 |
Nippon Chemiphar Co., Ltd. |
Ppardelta activators
|
ATE368653T1
(de)
|
2000-08-23 |
2007-08-15 |
Lilly Co Eli |
Oxazolylaryloxyessigsäure derivate und ihre verwendung als ppar agonisten
|
US6630504B2
(en)
|
2000-08-31 |
2003-10-07 |
Pfizer Inc. |
Phenoxyphenylheterocyclyl derivatives as SSRIs
|
GB0024361D0
(en)
|
2000-10-05 |
2000-11-22 |
Glaxo Group Ltd |
Medicaments
|
WO2002046154A1
(en)
|
2000-12-05 |
2002-06-13 |
Nippon Chemiphar Co., Ltd. |
Peroxisome proliferator activated receptor d activators
|
GB0031107D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
GB0031103D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
GB0031109D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
CA2433573A1
(en)
|
2000-12-28 |
2002-07-11 |
Takeda Chemical Industries, Ltd. |
Alkanoic acid derivatives, process for their production and use thereof
|
EP1357914A2
(de)
|
2001-02-02 |
2003-11-05 |
SmithKline Beecham Corporation |
Verfahren zur behandlung von ppar vermittelten krankheiten
|
WO2002076957A1
(fr)
|
2001-03-23 |
2002-10-03 |
Nippon Chemiphar Co.,Ltd. |
Activateur de recepteur active par les proliferateurs du peroxysome
|
JP4256166B2
(ja)
|
2001-03-28 |
2009-04-22 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
カルボン酸化合物
|
WO2002080899A1
(fr)
|
2001-03-30 |
2002-10-17 |
Eisai Co., Ltd. |
Agent de traitement de maladie digestive
|
TWI311133B
(en)
|
2001-04-20 |
2009-06-21 |
Eisai R&D Man Co Ltd |
Carboxylic acid derivativeand the salt thereof
|
WO2002098840A1
(fr)
|
2001-06-04 |
2002-12-12 |
Eisai Co., Ltd. |
Derive de l'acide carboxylique et medicament comprenant un sel ou un ester dudit derive
|
DE10130812A1
(de)
|
2001-06-26 |
2003-01-02 |
Zf Lenksysteme Gmbh |
Hilfskraftlenkung
|
FR2826574B1
(fr)
|
2001-06-29 |
2005-08-26 |
Oreal |
Compositions contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles
|
JP2004536152A
(ja)
|
2001-07-30 |
2004-12-02 |
ノボ ノルディスク アクティーゼルスカブ |
新規ビニルn−(2−ベンゾイルフェニル)−l−チロシン誘導体及び抗糖尿病剤等へのそれらの使用
|
JP2004536150A
(ja)
|
2001-07-30 |
2004-12-02 |
ノボ ノルディスク アクティーゼルスカブ |
新規なビニル、カルボン酸誘導体および抗生物質などとしてのそれらの使用
|
US6869967B2
(en)
|
2001-07-30 |
2005-03-22 |
Novo Nordisk A/S |
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
|
ATE526319T1
(de)
|
2001-08-10 |
2011-10-15 |
Nippon Chemiphar Co |
Aktivator für den peroxisome proliferator- responsiven rezeptor delta
|
WO2003016265A1
(fr)
|
2001-08-17 |
2003-02-27 |
Eisai Co., Ltd. |
Compose cyclique et agoniste du recepteur ppar
|
MXPA04002330A
(es)
|
2001-09-14 |
2005-04-08 |
Japan Tobacco Inc |
Compuestos biarilo ligados.
|
IL161351A0
(en)
|
2001-10-12 |
2004-09-27 |
Nippon Chemiphar Co |
ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR delta
|
DE10151390A1
(de)
|
2001-10-18 |
2003-05-08 |
Bayer Ag |
Essigsäurederivate
|
JP2003171275A
(ja)
|
2001-12-11 |
2003-06-17 |
Sumitomo Pharmaceut Co Ltd |
PPARδアゴニスト
|
WO2003072100A1
(en)
|
2002-02-25 |
2003-09-04 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
WO2003074495A1
(en)
|
2002-03-01 |
2003-09-12 |
Smithkline Beecham Corporation |
Hppars activators
|
US6867224B2
(en)
|
2002-03-07 |
2005-03-15 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods of preparation
|
US20030207924A1
(en)
|
2002-03-07 |
2003-11-06 |
Xue-Min Cheng |
Compounds that modulate PPAR activity and methods of preparation
|
US6833380B2
(en)
|
2002-03-07 |
2004-12-21 |
Warner-Lambert Company, Llc |
Compounds that modulate PPAR activity and methods of preparation
|
US6875780B2
(en)
*
|
2002-04-05 |
2005-04-05 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods for their preparation
|
DE10222034A1
(de)
|
2002-05-17 |
2003-11-27 |
Bayer Ag |
Tetrahydroisochinolin-Derivate
|
GB0214149D0
(en)
|
2002-06-19 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
GB0214254D0
(en)
|
2002-06-20 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
DE10229777A1
(de)
|
2002-07-03 |
2004-01-29 |
Bayer Ag |
Indolin-Phenylsulfonamid-Derivate
|
AU2003281040A1
(en)
|
2002-07-10 |
2004-02-02 |
Sumitomo Pharmaceuticals Co., Ltd. |
Biaryl derivatives
|
PL375700A1
(en)
*
|
2002-09-05 |
2005-12-12 |
Novo Nordisk A/S |
Novel vinyl carboxylic acid derivatives and their therapeutical use
|
EP1558572B1
(de)
*
|
2002-10-28 |
2010-06-30 |
High Point Pharmaceuticals, LLC |
Neue verbindungen und deren verwendung als ppar-modulatoren
|
US7129268B2
(en)
|
2002-10-28 |
2006-10-31 |
Novo Nordisk A/S |
Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
|
US20050080115A1
(en)
|
2002-10-28 |
2005-04-14 |
Lone Jeppesen |
Novel compounds, their preparation and use
|
KR20050055790A
(ko)
*
|
2002-10-28 |
2005-06-13 |
노보 노르디스크 에이/에스 |
Ppar 매개 질환의 치료에 유용한 신규 화합물
|
US7396850B2
(en)
|
2003-01-06 |
2008-07-08 |
Eli Lilly And Company |
Pyrazole derivative as PPAR modulator
|
DE10300099A1
(de)
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Indol-Phenylsulfonamid-Derivate
|
BRPI0407180A
(pt)
|
2003-02-14 |
2006-02-07 |
Lilly Co Eli |
Composto, composição farmacêutica, métodos para modular um receptor ativado pelo proliferador de peroxissoma, para tratar ou prevenir uma doença ou condição, para diminuir a glicose no sangue em um mamìfero, para tratar ou prevenir diabetes mellitus, doença cardiovascular e sìndrome x em um mamìfero, e, uso de um composto
|
JPWO2004080943A1
(ja)
|
2003-03-11 |
2006-06-08 |
小野薬品工業株式会社 |
シンナミルアルコール誘導体化合物およびその化合物を有効成分として含有する薬剤
|
CA2518986A1
(en)
|
2003-03-13 |
2004-09-23 |
Ono Pharmaceutical Co., Ltd. |
Imino ether derivative compounds and drugs containing the compounds as the active ingredient
|
CA2521175A1
(en)
|
2003-04-07 |
2004-10-28 |
Kalypsys, Inc. |
Para-sulfonyl substituted phenyl compounds as modulators of ppars
|
US20050070532A1
(en)
|
2003-04-17 |
2005-03-31 |
Liu Kevin |
Aryl compounds as modulators of PPARS and methods of treating metabolic disorders
|
CN1812978A
(zh)
|
2003-04-30 |
2006-08-02 |
药物研发有限责任公司 |
作为蛋白酪氨酸磷酸酶-1b抑制剂的苯基取代羧酸
|
ES2299906T3
(es)
|
2003-11-25 |
2008-06-01 |
Eli Lilly And Company |
Moduladores de receptores activados por proliferadores de peroxisomas.
|
EP1737440A2
(de)
|
2004-04-01 |
2007-01-03 |
Aventis Pharmaceuticals, Inc. |
Verwendung von ppar delta agonisten zur behandlung von demyelisierenden erkrankungen
|
DE602005027677D1
(de)
|
2004-04-01 |
2011-06-09 |
Aventis Pharma Inc |
1,3,4-oxadiazol-2-one als ppar-delta-modulatoren und deren verwendung
|
CN1956984B
(zh)
|
2004-04-01 |
2010-06-09 |
安万特药物公司 |
1,3,4-二唑-2-酮作为PPAR-δ调节剂
|
WO2005105725A1
(en)
|
2004-05-05 |
2005-11-10 |
Novo Nordisk A/S |
Novel compounds, their preparation and use
|
WO2005105735A1
(en)
|
2004-05-05 |
2005-11-10 |
Novo Nordisk A/S |
Phenoxyacetic acid derivatives as ppar agonists
|
EP2386540A1
(de)
|
2005-12-22 |
2011-11-16 |
High Point Pharmaceuticals, LLC |
Neue Verbindungen, ihre Herstellung und Verwendung
|
US7943612B2
(en)
|
2006-03-09 |
2011-05-17 |
High Point Pharmaceuticals, Llc |
Compounds that modulate PPAR activity, their preparation and use
|
WO2007141295A1
(en)
|
2006-06-08 |
2007-12-13 |
High Point Pharmaceuticals, Llc |
Process for preparing phenoxy acetic acid derivatives
|